Anabolic–androgenic steroids: How do they work and what are the risks?

P Bond, DL Smit, W de Ronde - Frontiers in Endocrinology, 2022 - frontiersin.org
Anabolic–androgenic steroids (AAS) are a class of hormones that are widely abused for
their muscle-building and strength-increasing properties in high, nontherapeutic, dosages …

Erectile dysfunction

FA Yafi, L Jenkins, M Albersen, G Corona… - Nature reviews Disease …, 2016 - nature.com
Erectile dysfunction is a multidimensional but common male sexual dysfunction that involves
an alteration in any of the components of the erectile response, including organic, relational …

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) The Fifth Joint Task Force of the European Society of Cardiology and …

European Journal of Preventive Cardiology, 2012 - journals.sagepub.com
Atherosclerotic cardiovascular disease (CVD) is a chronic disorder developing insidiously
throughout life and usually progressing to an advanced stage by the time symptoms occur. It …

Erectile dysfunction in young men—a review of the prevalence and risk factors

HMT Nguyen, AT Gabrielson… - Sexual medicine …, 2017 - academic.oup.com
Introduction Erectile dysfunction (ED) is an important health concern that can significantly
affect a man's psychosocial well-being. ED has traditionally been considered a disease of …

Erectile dysfunction

R Shamloul, H Ghanem - The Lancet, 2013 - thelancet.com
Erectile dysfunction is a common clinical entity that affects mainly men older than 40 years.
In addition to the classical causes of erectile dysfunction, such as diabetes mellitus and …

Sexual behavior in the United States: Results from a national probability sample of men and women ages 14–94

D Herbenick, M Reece, V Schick… - The journal of sexual …, 2010 - Wiley Online Library
Introduction. Despite a demonstrated relationship between sexual behaviors and health,
including clinical risks, little is known about contemporary sexual behavior. Aims. To assess …

A side effect resource to capture phenotypic effects of drugs

M Kuhn, M Campillos, I Letunic, LJ Jensen… - Molecular systems …, 2010 - embopress.org
The molecular understanding of phenotypes caused by drugs in humans is essential for
elucidating mechanisms of action and for developing personalized medicines. Side effects …

Pharmacotherapy for erectile dysfunction: recommendations from the Fourth International Consultation for Sexual Medicine (ICSM 2015)

K Hatzimouratidis, A Salonia, G Adaikan… - The journal of sexual …, 2016 - academic.oup.com
Introduction Treatment of erectile dysfunction is based on pharmacotherapy for most
patients. Aim To review the current data on pharmacotherapy for erectile dysfunction based …

Sexual activity and cardiovascular disease: a scientific statement from the American Heart Association

GN Levine, EE Steinke, FG Bakaeen, B Bozkurt… - Circulation, 2012 - Am Heart Assoc
Sexual activity is an important component of patient and partner quality of life for men and
women with cardiovascular disease (CVD), including many elderly patients. 1 Decreased …

Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and …

H Brunner, JR Cockcroft, J Deanfield… - Journal of …, 2005 - journals.lww.com
Dysfunction of the vascular endothelium is a hallmark of most conditions that are associated
with atherosclerosis and is therefore held to be an early feature in atherogenesis. However …